STK11 and ovarian carcinoma: Transiently knocking down LKB1 with siRNA technology resulted in reduced viability in ovarian cancer cells growing as spheroids but not as adherent cells [132], providing more context to the possible role of LKB1 loss of function in cancer initiation [134].